Subscribe to Newsletter

July 2021 Issue of The Medicine Maker

Our July issue celebrates the grand winner of our 2020 Innovation Awards: the Smart Container from Schott which improves visibility into fill and finish processes. Elsewhere in the issue, we cover 3D printing, digital technology, and cyberattacks – in Upfront – and CRISPR-engineered cell therapies, continuous biomanufacturing, and gender diversity – in In My View. We also have articles on the UK’s Vaccine Taskforce, improving clinical trials, and the latest breakthroughs in cell and gene. Finally, we sit down with Sudarshan Jain, Secretary-General of the Indian Pharmaceutical Alliance.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Business & Regulation Business Practice

The Digital Advantage

| Maryam Mahdi

How can pharma make the most of digital technologies?

Manufacture Technology and Equipment

Just Press Print

| Maryam Mahdi

Bringing customized medicines to patients with additive manufacturing.
Business & Regulation Standards & Regulation

A Year Like No Other

| Maryam Mahdi

The EMA releases its annual report highlighting its achievements throughout 2020.
Business & Regulation Business Practice

Take Care of Yourself!

| Maryam Mahdi

How is the OTC industry rising to pharma's biggest challenges?
Business & Regulation COVID-19

COVID-19’s Digital Legacy

| Claire Hill

Efficient data management is critical to meet the demand for fast drug development – especially in light of COVID-19
Discovery & Development Advanced Medicine

Don’t Break My Strands

| Emily M. Anderson

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.
Business & Regulation Clinical Trials

Inclusive Drug Development

| Ann Taylor

The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.
Manufacture Bioprocessing - Single Use Systems

Continuous: Before you Leap, Consider this

| Niklas Jungnelius

Is there data demonstrating significant cost benefits from continuous biomanufacturing?
Manufacture Digital Technologies

Future Sight

How individually coded vials give manufacturers the ability to track vials moving through fill and finish lines.
Manufacture Bioprocessing - Upstream & Downstream

Boosting Cell Line Expression

Why is there a need for innovation in cell line development technology?

Business & Regulation Technology and Equipment

Supporting Patients During Treatment

How pharma can support patients with initial onboarding and ongoing adherence to therapeutic treatments.
Discovery & Development Clinical Trials

Clinical Trials and Tribulations

| Maryam Mahdi

When it comes to clinical trials, is pharma making the best use of digital technologies?

Business & Regulation Business Practice

The Human Yin to the Clinical Yang

| Maryam Mahdi

How can advocacy groups help improve the clinical trials landscape?
Business & Regulation Profession

People, Process, Product: Lessons Learned with Antoinette Gawin

| James Strachan

Find out how a random act of kindness set Antoinette Gawin on the path to becoming a VP in her twenties.
Discovery & Development Advanced Medicine

Understanding the Three Levels of Genetic Medicine

| James Strachan

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.
Business & Regulation Drug Delivery

What's New from The Cell + Gene Curator?

| James Strachan

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.
Business & Regulation COVID-19

COVID-19: Inside the UK's Vaccine Taskforce

| James Strachan

Steve Bates gives us the inside scoop on the UK’s Vaccine Taskforce.
Business & Regulation Profession

Learning Never Stops

| Maryam Mahdi

Sitting Down With… Sudarshan Jain, Secretary-General of the Indian Pharmaceutical Alliance.

Other issues of 2021